Why the study?
What is the relationship between myocardial and serum concentrations of digitoxin and its metabolites in patients on maintenance treatment?
What is the relationship between myocardial and serum concentrations of digitoxin and its metabolites in patients on maintenance treatment?
Digitoxin and its metabolites show high affinity for the myocardium, with significant differences in metabolic patterns between myocardium and serum.
Answers are grounded in this paper and cite their sources.
Serum digitoxin levels may not reflect myocardial exposure; cross-sectional data leaves open tissue-specific pharmacokinetic questions.
The levels of digitoxin and cardioactive metabolites were measured in 42 atrial biopsies with a 86Rb method modified for analysis of myocardial samples. The mean value was 91.0 ng/gm wet weight (SD 54.4). Myocardial and serum concentrations were compared in 23 patients; there was no significant correlation. The ratio of total drug concentration in myocardium and serum ranged from 1 to 38 with a mean value of 5.4. Calculated from the free drug concentrations, the mean myocardial serum ratio was 200, which reflects the high affinity of digitoxin and cardioactive metabolites to the myocardium. The metabolic pattern of cardioactive and inactive metabolites (conjugates with glucuronic and sulfuric acid) was studied in autopsy samples from left ventricular myocardium from 7 patients. Significant differences between the myocardial and serum patterns of cardioactive and inactive metabolites were demonstrated. The myocardium contained less unchanged digitoxin (25.7%) and more hydrolyzed (55.4%) and conjugated (54.1%) metabolites than serum (57.6%, 31.0%, and 33.1%, respectively). Hydroxylated metabolites in myocardium (15.8%) were not significantly changed compared to serum (10.0%).
No takes yet. Share an insight, caveat, or question.
Liv Storstein (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: